Opens in a new tab

Dr. Liu Huishu

Chinese name: 刘慧姝
Chief Physician, Professor, Doctoral Supervisor . Obstetrics & Maternal-Fetal Medicine
Dr. Liu Huishu is Director of Obstetrics, head of the obstetrics teaching and research office and academic leader of obstetrics at Guangzhou Women and Children's Medical Center. A professor and doctoral supervisor, she specialises in high-risk pregnancy, obstetric critical care and maternal-fetal medicine.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

over 30 years
Clinical experience in obstetrics
60+ (12 SCI)
Papers published
3
National Natural Science Foundation projects

  • The Physician

About Dr. Liu Huishu

Dr. Liu Huishu is Director of Obstetrics and academic leader of the department at Guangzhou Women and Children's Medical Center, and a professor, chief physician and doctoral supervisor. She has more than twenty-five years of experience in obstetrics, with expertise in high-risk pregnancy, obstetric critical care and maternal-fetal medicine. She has directed the rescue of nearly one thousand critically ill pregnant women and leads research on pre-eclampsia, preterm birth and placental disease. She has led three National Natural Science Foundation general projects and published more than sixty papers, including twelve SCI articles, and helped build a regional referral system for critically ill mothers.
1、Director of Obstetrics and academic leader of obstetrics at Guangzhou Women and Children’s Medical Center
2、Professor, Chief Physician and Doctoral Supervisor
3、Executive member for China of the International Society for the Study of Hypertension in Pregnancy (ISSHP)
4、Vice Chairman of the Guangdong Medical Association Perinatal Medicine Branch and Chairman of the Guangzhou Perinatal Medicine Society
5、Associate editor of the Chinese Journal of Obstetric Emergency and editorial board member of Hypertension in Pregnancy
6、Principal investigator of three National Natural Science Foundation projects on pre-eclampsia and preterm birth

Dr. Liu Huishu ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

High-risk pregnancy

She manages pregnancies complicated by multiple gestation, placenta praevia, hypertensive disorders, preterm labour and medical conditions such as heart, liver, thyroid and platelet disease, providing careful antenatal surveillance and delivery planning to protect both mother and baby through pregnancy and childbirth.

Obstetric critical care

She leads the rescue and transfer of women with life-threatening obstetric emergencies, including postpartum haemorrhage, amniotic fluid embolism and eclampsia, coordinating multidisciplinary teams to stabilise patients rapidly, reduce maternal mortality and protect the health of mothers in the most severe cases.

Maternal-fetal medicine and placental disease

She diagnoses and manages placental disorders such as placenta praevia and placenta accreta, and leads research on pre-eclampsia and preterm birth, using imaging and close monitoring to guide delivery timing and improve outcomes for mothers and newborns across pregnancy and the postpartum period.

More： preterm birth——prevention and management; twin pregnancy——antenatal care; gestational hypertension——treatment; postpartum haemorrhage——emergency care; fetal surveillance——monitoring

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Perinatal Care to Prevent Mother-to-Child Transmission of Hepatitis B
Published in The BMJ, this study addressed prevention of mother-to-child transmission of hepatitis B virus, reviewing antiviral treatment and infant immunoprophylaxis around delivery. It provides practical guidance for managing pregnant women with chronic hepatitis B so that newborns are protected from infection.
2. sFlt-1/PlGF Ratio for Predicting Preeclampsia
This study evaluated the angiogenic markers sFlt-1 and PlGF for predicting and diagnosing preeclampsia, a hypertensive disorder of pregnancy. Measuring their ratio improved risk assessment and helped clinicians decide on monitoring and timely delivery, reducing maternal and fetal complications for women with suspected preeclampsia.
3. Single-Cell Analysis of Placenta Accreta Spectrum
Using single-cell sequencing of placental tissue, this study characterised the cellular changes underlying placenta accreta spectrum, a life-threatening condition in which the placenta invades the uterine wall. The findings shed light on abnormal trophoblast invasion and may inform diagnosis and management of women at risk of severe postpartum haemorrhage.
4. Molecular Mechanisms of Labour Onset in the Myometrium
This research investigated the role of the gene SERPINE1 and related pathways in human myometrium during labour, exploring how inflammation and extracellular matrix remodelling trigger uterine contractions. Understanding these mechanisms may help predict preterm labour and guide treatments for women with threatened premature birth.
5. Effects of Nicotine and Inflammation on Pregnancy Outcome
This experimental study examined how nicotine exposure combined with inflammation affects pregnancy, focusing on mechanisms that may contribute to preterm birth and fetal injury. The work helps explain how smoking and infection interact to raise obstetric risk, informing counselling for pregnant women to quit smoking and control infection.
6. Research Profile in Obstetrics and Maternal-Fetal Medicine
This researcher profile lists publications and activities in obstetrics and maternal-fetal medicine, covering hypertensive disorders, placenta accreta spectrum, preterm labour, fetal medicine and critical obstetric care. It offers a consolidated view of studies guiding diagnosis, monitoring and treatment for women with high-risk pregnancies.
  • Affiliated Hospital

Where Dr. Liu Huishu practices

Guangzhou

Guangzhou Women and Children’s Medical Center

Chinese name: 广州医科大学附属妇女儿童医疗中心
Guangzhou Women and Children's Medical Center, South China's largest public women's and children's tertiary hospital since its founding in 2006, is the national children's regional medical center holding 8 national key specialties, 2,400 beds, JCI accreditation and the top A national performance grade.
Since 2006
20 years of women & child care
2,400
Licensed beds
4.89 million (2025)
Annual outpatient visits
Since 2012
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Liu Huishu?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Liu Huishu.